BioHealth News Archive
Vaccitech Awarded U.K. Grant for COVID Vaccine Research
Vaccitech officials say the company received a U.K. government grant to support research with its next-generation technology platform to protect against COVID-19. The grant…
Read More
Alexandria Venture Investments Recognized as #1 Most Active Biopharma Investor for Third Consecutive Year
PASADENA, Calif., Sept. 4, 2020 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban…
Read More
Sanofi, GSK start human trial of their COVID-19 vaccine
Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a clinical trial for their jointly developed COVID-19 vaccine candidate. A total of…
Read More
Skincare of the Future QuickFire Challenge – Challenge | JLABS
Advances in science and technology can drive the next generation of skincare innovations. Today, cutting edge dermatological research and technologies hold the potential to revolutionize pore minimizing and anti-aging solutions. To that end, Johnson &…
Read More
Nobelpharma Press Release — MCEDC
ROCKVILLE, Md. — Recognizing the benefits of proximity to leading U.S. researchers, regulators and advocacy groups, Nobelpharma America, LLC has chosen Montgomery County, Maryland…
Read More
TruGenomix, a Veteran-Led Biotech Instrumental in Early Identification & Awareness of PTSD, Raises $1.8 Million Seed Round, Led by Sanford Health & Viking Global
TruGenomix recently announced $1.8 million in financing in a seed round led by Sanford Health. The startup, a graduate of the Illumina Accelerator program…
Read MoreBiotech leaders call for Covid-19 data transparency, FDA independence
WASHINGTON — A group of prominent biotech CEOs are calling on their peers and the federal government to hold themselves to the highest standards…
Read More
Ceres Nanosciences Receives $6.5M NIH Award
MANASSAS, Va. — September 2, 2020 — Ceres Nanosciences, a privately held company that makes innovative products to improve diagnostic testing, announced it has been…
Read More
NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test
CHARLOTTESVILLE, Va., Sept. 2, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to $40.9 million by the National Institutes of Health (NIH),…
Read More
AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine
AstraZeneca said today it has launched a 30,000-patient Phase III trial in the U.S. of AZD1222, the COVID-19 vaccine it is co-developing with the…
Read More
California developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal
The 170,000-square-foot building would be located near Rye Street Tavern. {iframe}https://www.bizjournals.com/baltimore/news/2020/09/01/alexandria-proposes-port-covington-building.html{/iframe}
Read More
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS
WASHINGTON, D.C., August 27, 2020 - Johnson & Johnson Innovation LLC today announced the first companies to be part of its medical countermeasure innovation…
Read More
American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure | BioSpace
HIV therapies, typically cocktails of antiviral drugs, have proven to be very successful in controlling HIV/AIDS. However, they are not a “cure,” which is…
Read More
Emergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day | BioSpace
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it is teaming up with the Boston Red…
Read More
Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups – Vaccitech
Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces that the development of AstraZeneca’s AZD1222 vaccine…
Read More